[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335447-105":59,"doc-detail-335447-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","effects-of-differentially-methylated-cpg-sites-in-enhancer-and-promoter-regions-on-the-chromatin-structures-of-target-lncrnas-in-breast-cancer","Effects of Differentially Methylated CpG Sites in Enhancer and Promoter Regions on the Chromatin Structures of Target LncRNAs in Breast Cancer","","Aberrant DNA methylation drives breast cancer progression by controlling gene expression, yet the methylation regulatory landscape in long noncoding RNAs (lncRNAs) is not fully resolved. This study integrates gene expression, DNA methylation, and clinical data from TCGA patients to characterize methylation across lncRNA categories. Genome-wide and Hi-C analyses identify CpG sites in lncRNAs and distally associated CpGs, linking differentially methylated sites in promoters and enhancers to 3D chromatin enhancer–promoter loop formation. Using Cox regression and three machine-learning models, 11 key methylation-driven lncRNAs are used to build a prognostic risk scoring model with strong performance, supporting potential diagnostic biomarkers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/effects-of-differentially-methylated-cpg-sites-in-enhancer-and-promoter-regions-on-the-chromatin-structures-of-target-lncrnas-in-breast-cancer/335447/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/effects-of-differentially-methylated-cpg-sites-in-enhancer-and-promoter-regions-on-the-chromatin-structures-of-target-lncrnas-in-breast-cancer/335447.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the study on breast cancer?","Question",{"text":112,"@type":113},"The study investigates how differentially methylated CpG sites in enhancer and promoter regions relate to chromatin structures of target lncRNAs in breast cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were DNA methylation patterns and CpG sites analyzed?",{"text":117,"@type":113},"The analysis integrates gene expression, DNA methylation, and clinical data from TCGA, using genome-wide correlation to identify CpG sites in lncRNAs and distally associated CpGs.",{"name":119,"@type":110,"acceptedAnswer":120},"How were key lncRNAs and a prognostic model identified?",{"text":121,"@type":113},"Cox regression and three machine learning models were used to select 11 methylation-driven lncRNAs and construct a prognostic risk scoring model, showing strong prognostic performance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335447,1790758046,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nEffects of Differentially Methylated CpG Sites in Enhancer and Promoter Regions on the Chromatin Structures of Target LncRNAs in Breast Cancer  \nZhiyu Fan 1, Yingli Chen 1,2,*, Dongsheng Yan 1 and Qianzhong Li 1,2  \nCitation: Fan, Z.; Chen, Y.; Yan, D.; Li, Q. Effects of Differentially Methylated CpG Sites in Enhancer and Promoter Regions on the Chromatin Structures of Target LncRNAs in Breast Cancer. Int. J. Mol. Sci. 2024, 25, 11048 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms252011048  \n1 School of Physical Science and Technology, Inner Mongolia University, Hohhot 010021, China; [22146006@mail.imu.edu.cn](22146006@mail.imu.edu.cn) (Z.F.); [yds015017@163.com](yds015017@163.com) (D.Y.); [qzli@imu.edu.cn](qzli@imu.edu.cn) (Q.L.)  \n2 The State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Inner Mongolia University, Hohhot 010021, China  \n* Correspondence: [stchenyl@imu.edu.cn](stchenyl@imu.edu.cn); Tel.: +86-471-499-2914  \nAbstract: Aberrant DNA methylation plays a crucial role in breast cancer progression by regulating gene expression. However, the regulatory pattern of DNA methylation in long noncoding RNAs (lncRNAs) for breast cancer remains unclear. In this study, we integrated gene expression, DNA methylation, and clinical data from breast cancer patients included in The Cancer Genome Atlas (TCGA) database. We examined DNA methylation distribution across various lncRNA categories, revealing distinct methylation characteristics. Through genome-wide correlation analysis, we identified the CpG sites located in lncRNAs and the distally associated CpG sites of lncRNAs. Functional genome enrichment analysis, conducted through the integration of ENCODE ChIP-seq data, revealed that differentially methylated CpG sites (DMCs) in lncRNAs were mostly located in promoter regions, while distally associated DMCs primarily acted on enhancer regions. By integrating Hi-C data, we found that DMCs in enhancer and promoter regions were closely associated with the changes in three-dimensional chromatin structures by affecting the formation of enhancer–promoter loops. Furthermore, through Cox regression analysis and three machine learning models, we identified 11 key methylation-driven lncRNAs (DIO3OS, ELOVL2-AS1, MIAT, LINC00536, C9orf163, AC105398.1, LINC02178, MILIP, HID1-AS1, KCNH1-IT1, and TMEM220-AS1) that were associated with the survival of breast cancer patients and constructed a prognostic risk scoring model, which demonstrated strong prognostic performance. These findings enhance our understanding of DNA methylation’s role in lncRNA regulation in breast cancer and provide potential biomarkers for diagnosis.  \nKeywords: DNA methylation; lncRNA; enhancer; promoter; Hi-C; breast cancer  \n1. Introduction  \nAcademic Editor: Shinichi Fukushige  \nReceived: 3 September 2024  \nRevised: 7 October 2024  \nAccepted: 11 October 2024  \nPublished: 15 October 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nBreast cancer is among the most prevalent cancers worldwide, and it is a leading cause of cancer-related mortality in women [1] . Therefore, it is crucial to obtain a deeper understanding of the molecular regulatory mechanisms underlying breast cancer to improve its diagnosis, treatment, and prognosis. Long noncoding RNAs (lncRNAs) are a class of transcripts longer than 200 nucleotides with no or limited protein-coding ability [2] . Accumulating evidence has shown that lncRNAs are involved in various biological processes, including cell proliferation, apoptosis, differentiation, tumorigenesis, and metastasis [3,4] . In breast cancer, the expression of ","cbCairSAB2b2riq9","https://ap.wps.com/l/cbCairSAB2b2riq9","pdf",17337227,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main focus of the study on breast cancer?\",\"answer\":\"The study investigates how differentially methylated CpG sites in enhancer and promoter regions relate to chromatin structures of target lncRNAs in breast cancer.\"},{\"question\":\"How were DNA methylation patterns and CpG sites analyzed?\",\"answer\":\"The analysis integrates gene expression, DNA methylation, and clinical data from TCGA, using genome-wide correlation to identify CpG sites in lncRNAs and distally associated CpGs.\"},{\"question\":\"How were key lncRNAs and a prognostic model identified?\",\"answer\":\"Cox regression and three machine learning models were used to select 11 methylation-driven lncRNAs and construct a prognostic risk scoring model, showing strong prognostic performance.\"}]","Effects of Differentially Methylated CpG Sites in Enhancer and Promoter Regions on the Chromatin Structures of Target LncRNAs in Breast Cancer | PDF",1790011020,48]